Quest DiagnosticsDGX
NYSEMedical Laboratories
No cached AI snapshot yet for DGX.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
57,000 employees111.00M shares outstandinglisted 1996-12-17dividend yield 1.76%
Next earnings ~Aug 3, 2026 · Ex-dividend Apr 6, 2026 · Dividend $0.86 quarterly
About Quest Diagnostics
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Latest News
Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript
Quest Diagnostics Incorporated (DGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Quest Diagnostics at Morgan Stanley conference: growth broadens
FOMC preview: Rate hike priced in as markets await policy guidance
Euro: Firm Dollar keeps pressure on Euro before FOMC - Danske Bank
FOMC day
Related Stocksin Medical Laboratories
Ready to see the live AI view on DGX?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing DGX side-by-side with live signals.